SECOND BIOLOGICAL DMARD THERAPY IN RHEUMATOID ARTHRITIS: A RETROSPECTIVE COHORT ANALYSIS

被引：0
|
作者：
Saadaoui, K. [1 ]
Sahli, H. [1 ]
Jemmali, S. [1 ]
Boussaid, S. [1 ]
Rekik, S. [1 ]
Cheour, E. [1 ]
Elleuch, M. [1 ]
机构：
[1] La Rabta Hosp, Rheumatol, Tunis, Tunisia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷
关键词：
D O I：
10.1136/annrheumdis-2021-eular.3871
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0238
引用
收藏
页码：1144 / 1145
页数：2
相关论文
共 50 条
  • [21] Combination DMARD therapy including corticosteroids in early rheumatoid arthritis
    Möttönen, TT
    Hannonen, PJ
    Boers, M
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S59 - S65
  • [22] EARLIER DMARD THERAPY IN RHEUMATOID ARTHRITIS- ARE WE SUCCEEDING?
    McEntegart, A.
    Wood, F.
    Capell, H. A.
    Porter, D.
    Hunter, J.
    Madhok, R.
    RHEUMATOLOGY, 2002, 41 : 95 - 95
  • [23] Combination DMARD therapy for rheumatoid arthritis: A step closer to the goal
    ODell, JR
    ANNALS OF THE RHEUMATIC DISEASES, 1996, 55 (11) : 781 - 783
  • [24] EFFECTIVENESS AND COSTS OF CONVENTIONAL DMARD THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Buitrago-Garcia, D.
    Villarreal, L.
    Alvis-Zakzuk, N.
    Carrasquilla, M.
    Alvis Guzman, N.
    VALUE IN HEALTH, 2018, 21 : S196 - S196
  • [25] Analysis of the Reasons for DMARD Therapy Discontinuation in Patients with Rheumatoid Arthritis in the Czech and Slovak Republics
    K. Pavelka
    Š. Forejtová
    A. Pavelková
    J. Zvárová
    J. Rovenský
    A. Tuchyňová
    Clinical Rheumatology, 2002, 21 : 220 - 226
  • [26] Analysis of the reasons for DMARD therapy discontinuation in patients with rheumatoid arthritis in the Czech and Slovak republics
    Pavelka, K
    Forejtová, S
    Pavelková, A
    Zvárová, J
    Rovensky, J
    Tuchynová, A
    CLINICAL RHEUMATOLOGY, 2002, 21 (03) : 220 - 226
  • [27] INITIAL TRIPLE DMARD THERAPY PREDICTS ACR EULAR REMISSION IN AN EARLY RHEUMATOID ARTHRITIS INCEPTION COHORT
    Chitale, Sarang
    Estrach, Cristina
    Moots, Robert J.
    Goodson, Nicola J.
    RHEUMATOLOGY, 2012, 51 : 162 - 162
  • [28] Refining strategies for biological and targeted synthetic DMARD initiation in rheumatoid arthritis
    Liu, Sijia
    Ma, Jialao
    LANCET RHEUMATOLOGY, 2025, 7 (03): : e159 - e159
  • [29] BIOLOGICAL DMARD RETENTION RATES IN RHEUMATOID ARTHRITIS: A 10 YEAR STUDY
    Bhushan, Vandana
    Hijjawi, Raif
    Walker, Jennifer
    Pontifex, Eliza
    Cai, Fin
    Shanahan, E. Michael
    Briggs, Liz
    Ninan, Jem
    Goldblatt, Fiona
    Wechalekar, Mihir D.
    INTERNAL MEDICINE JOURNAL, 2020, 50 : 49 - 49
  • [30] COSTS AND TRENDS IN THE USAGE OF BIOLOGICAL THERAPY FOR RHEUMATOID ARTHRITIS -A RETROSPECTIVE STUDY
    Santos-Moreno, P.
    Buitrago-Garcia, D.
    Villarreal, L.
    Alvis-Zakzuk, N.
    Carrasquilla, M.
    Alvis Guzman, N.
    VALUE IN HEALTH, 2018, 21 : S195 - S195
12345